Loading...
•
Dec 31, 2021
Acadia Healthcare Q4 2021 Earnings Report
Acadia Healthcare's Q4 2021 financial results were announced, showing revenue growth and strategic investments.
Key Takeaways
Acadia Healthcare reported a revenue of $593.5 million for Q4 2021, a 10.7% increase in same facility revenue, and a net income of $70.3 million, or $0.77 per diluted share.
Revenue totaled $593.5 million.
Same facility revenue increased 10.7% compared to Q4 2020.
Net income attributable to Acadia Healthcare Company, Inc. totaled $70.3 million, or $0.77 per diluted share.
The company completed the acquisition of CenterPointe Behavioral Health System in Missouri.
Forward Guidance
Acadia provided financial guidance for 2022, projecting revenue between $2.55 to $2.60 billion and adjusted earnings per diluted share between $2.85 to $3.15.
Positive Outlook
- Revenue $2.55 to $2.60 billion
- Adjusted EBITDA $575 to $610 million
- Adjusted earnings per diluted share $2.85 to $3.15
- Operating cash flows, including $39 million of CARES Act repayments $350 to $400 million
- Primary objective for 2022 is to continue to extend our market reach with a goal to add 300 beds to existing facilities and pursue additional opportunities for de novo facilities, joint venture partnerships and acquisitions
Challenges Ahead
- Interest Expense $65 to $70 million
- Tax rate 25% to 26%
- Depreciation and amortization expense $120 to $130 million
- Stock compensation expense Approximately $30 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...